Preventing Hepatitis B Reactivation During Anti‐CD20 Antibody Treatment in the Veterans Health Administration

Hepatitis B virus (HBV) reactivation may occur with high risk immunosuppression, such as anti‐cluster of differentiation (CD)20 antibodies (Abs). Appropriate HBV prophylaxis during anti‐CD20 Ab therapy averts hepatitis, chemotherapy disruption, and death. Serologic evidence of prior HBV exposure is...

Full beskrivning

Bibliografiska uppgifter
Huvudupphovsmän: Jasmine Bullard, A., Cunningham, Francesca E., Volpp, Bryan D., Lowy, Elliott, Beste, Lauren A., Heron, Bernadette B., Geraci, Mark, Hammond, Julia M., LaPlant, Kourtney, Stave, Elise A., Turner, Marsha J., O’Leary, Meghan C., Kelley, Michael J., Hunt, Christine M.
Materialtyp: Online Artikel Text
Språk:English
Publicerad: John Wiley and Sons Inc. 2018
Ämnen:
Original Articles
Länkar:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6128236/
https://www.ncbi.nlm.nih.gov/pubmed/30202826
http://dx.doi.org/10.1002/hep4.1238

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6128236/
https://www.ncbi.nlm.nih.gov/pubmed/30202826
http://dx.doi.org/10.1002/hep4.1238

Liknande verk